Company Filing History:
Years Active: 1987
Title: Franz Radivojevich: Innovator in Coronary Therapeutics
Introduction
Franz Radivojevich is a notable inventor based in Zofingen, Switzerland. He has made significant contributions to the field of coronary therapeutics, particularly through his innovative approach to drug formulation.
Latest Patents
Radivojevich holds a patent for a coronary therapeutic agent in the form of soft gelatin capsules. This invention addresses previous challenges related to capsule size and the low concentration of the active substance, nifedipine. By utilizing PVP and dissolving nifedipine in THFP, he has developed a formulation that allows for a capsule weight of only 162 mg.
Career Highlights
Radivojevich is associated with Siegfried Aktiengesellschaft, a company known for its focus on pharmaceutical development and manufacturing. His work has contributed to advancements in the delivery of coronary therapeutic agents.
Collaborations
He has collaborated with notable colleagues, including Stephan Dvorsky and Hans Joss, to further enhance the development of innovative therapeutic solutions.
Conclusion
Franz Radivojevich's contributions to coronary therapeutics exemplify the impact of innovation in the pharmaceutical industry. His patent for a soft gelatin capsule formulation represents a significant advancement in drug delivery systems.